Filing Flows › Amneal Pharmaceuticals (AMRX) › How it makes money
How Amneal Pharmaceuticals (AMRX) makes money
Amneal Pharmaceuticals (AMRX) made $863M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Of every dollar of revenue, 39¢ was left as gross profit, 11¢ was left as operating profit, 1¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $863M | 100.0% |
| Cost of revenue | $529M | 61.3% |
| Gross profit | $334M | 38.7% |
| Operating expenses | $239M | 27.7% |
| Operating profit | $95.4M | 11.1% |
| Income tax | $2.8M | 0.3% |
| Net earnings | $12.3M | 1.4% |
| Operating cash flow | $98.3M | 11.4% |
| Free cash flow | $66.5M | 7.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $863M | +10% |
| Q2 2026 | $796M | +10% |
| Q1 2026 | $723M | +4% |
| Q4 2025 | $814M | +12% |
| Q3 2025 | $785M | +12% |
| Q2 2025 | $725M | +3% |
| Q1 2025 | $695M | +6% |
From Amneal Pharmaceuticals' 8-K filed Nov 3, 2026 (on EDGAR).
Questions
How does Amneal Pharmaceuticals make money?
Amneal Pharmaceuticals (AMRX) made $863M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Of every dollar of revenue, 39¢ was left as gross profit, 11¢ was left as operating profit, 1¢ was left as net earnings.
What is Amneal Pharmaceuticals' profit margin?
Net earnings were $12.3M, 1.4% of revenue, in the third quarter 2026; the operating margin was 11.1%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.